Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 2
2005 3
2006 2
2007 1
2008 3
2009 3
2010 7
2011 9
2012 2
2013 2
2014 5
2015 6
2016 3
2017 4
2018 6
2019 3
2020 3
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission.
Marks DI, Castleton A, Olavarria E, Gilleece M, Fielding A, Mikhaeel G, Beasley M, Diez P, Jackson A, Hodgkinson A, Elhanied M, Chakraverty R. Marks DI, et al. Among authors: chakraverty r. BMJ Open. 2023 Jun 1;13(6):e067790. doi: 10.1136/bmjopen-2022-067790. BMJ Open. 2023. PMID: 37263700 Free PMC article.
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.
Cheminant M, Fox TA, Alligon M, Bouaziz O, Neven B, Moshous D, Blanche S, Guffroy A, Fieschi C, Malphettes M, Schleinitz N, Perlat A, Viallard JF, Dhedin N, Sarrot-Reynauld F, Durieu I, Humbert S, Fouyssac F, Barlogis V, Carpenter B, Hough R, Laurence A, Marçais A, Chakraverty R, Hermine O, Fischer A, Burns SO, Mahlaoui N, Morris EC, Suarez F. Cheminant M, et al. Among authors: chakraverty r. Blood. 2023 Jan 5;141(1):60-71. doi: 10.1182/blood.2022015482. Blood. 2023. PMID: 36167031 Free article.
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Schetelig J, Chevallier P, van Gelder M, Hoek J, Hermine O, Chakraverty R, Browne P, Milpied N, Malagola M, Socié G, Delgado J, Deconinck E, Damaj G, Maury S, Beelen D, Quoc SN, Shankara P, Brecht A, Mayer J, Hunault-Berger M, Bittenbring J, Thieblemont C, Lepretre S, Baldauf H, de Wreede LC, Tournilhac O, Yakoub-Agha I, Kröger N, Dreger P. Schetelig J, et al. Among authors: chakraverty r. Bone Marrow Transplant. 2022 Feb;57(2):330. doi: 10.1038/s41409-021-01516-2. Bone Marrow Transplant. 2022. PMID: 34773088 Free PMC article. No abstract available.
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. Among authors: chakraverty r. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Marzolini MAV, Wilson AJ, Sanchez E, Carpenter B, Chakraverty R, Hough R, Kottaridis P, Morris EC, Thomson KJ, Peggs KS. Marzolini MAV, et al. Among authors: chakraverty r. Transplant Cell Ther. 2021 Aug;27(8):682.e1-682.e12. doi: 10.1016/j.jtct.2021.04.020. Epub 2021 May 4. Transplant Cell Ther. 2021. PMID: 33962069 Free article.
Graft Versus Leukemia: Current Status and Future Perspectives.
O'Neill AT, Chakraverty R. O'Neill AT, et al. Among authors: chakraverty r. J Clin Oncol. 2021 Feb 10;39(5):361-372. doi: 10.1200/JCO.20.01801. Epub 2021 Jan 12. J Clin Oncol. 2021. PMID: 33434054 Review. No abstract available.
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Cuadrado MM, Szydlo RM, Watts M, Patel N, Renshaw H, Dorman J, Lowdell M, Ings S, Anthias C, Madrigal A, Mackinnon S, Kottaridis P, Carpenter B, Hough R, Morris E, Thomson K, Peggs KS, Chakraverty R. Cuadrado MM, et al. Among authors: chakraverty r. Haematologica. 2020 Nov 1;105(11):2639-2646. doi: 10.3324/haematol.2019.226340. Haematologica. 2020. PMID: 33131253 Free PMC article.
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Schetelig J, Chevallier P, van Gelder M, Hoek J, Hermine O, Chakraverty R, Browne P, Milpied N, Malagola M, Socié G, Delgado J, Deconinck E, Damaj G, Maury S, Beelen D, Quoc SN, Shankara P, Brecht A, Mayer J, Hunault-Berger M, Bittenbring J, Thieblemont C, Lepretre S, Baldauf H, de Wreede LC, Tournilhac O, Yakoub-Agha I, Kröger N, Dreger P. Schetelig J, et al. Among authors: chakraverty r. Bone Marrow Transplant. 2021 Mar;56(3):605-613. doi: 10.1038/s41409-020-01069-w. Epub 2020 Oct 2. Bone Marrow Transplant. 2021. PMID: 33004942 Free PMC article.
72 results